The impact of soluble CEACAM5 on NILK-2301 functionality was assessed by TDCC in the presence of 0.02, 0.05 and 0.1 μg/mL soluble CEACAM5 for the three tumor cell lines mentioned above. This evidence concerns the gene CEACAM5 and neoplasm.